Biography:
Dr. Jakubik studied Immunology and Microbiology with a focus on HIV immune complex pathogenesis at Rush University Medical Center, Chicago, IL. Her career began at Millipore Corporation (Bedford, MA) and then she held scientific positions at pharmaceutical companies (Genetics Institute, Wyeth, Pfizer, Idenix) prior to leading teams developing and performing biofunctional assays for clinical trials at CROs (PPD, Precision for Medicine). This high-throughput infectious disease vaccine work led to a transition into a non-profit, Sabin Vaccine Institute (Washington D.C.), to delve into BSL-4 virus targets and vaccine development with USA government (BARDA) funding. Currently, Jocelyn is leading Serology Assay Development at Meso Scale Diagnostics, Rockville, MD and using her vast history in infectious disease to launch new products on MSD’s multiplex platform to address global disease surveillance, vaccine development and outbreak response.
Title : A novel multiplex serology assay to evaluate immune response to RSV, SARS CoV-2 and influenza
Title : Multiplexed serology assays for detection of IgG antibodies against Mpox and vaccinia viruses